Skip to main content

Market Overview

Natixis Upgrades Novartis To Buy


Analysts at Natixis upgraded Novartis AG (NYSE: NVS) from Neutral to Buy.

Novartis shares have gained 19.21% over the past 52 weeks, while the S&P 500 index has surged 12.49% in the same period.

Novartis' shares fell 0.32% to $98.74 in pre-market trading.

Latest Ratings for NVS

Mar 2021Argus ResearchDowngradesBuyHold
Feb 2021Cowen & Co.DowngradesOutperformMarket Perform
Jan 2021Deutsche BankInitiates Coverage OnBuy

View More Analyst Ratings for NVS
View the Latest Analyst Ratings


Related Articles (NVS)

View Comments and Join the Discussion!

Posted-In: NatixisUpgrades Analyst Ratings

Latest Ratings

GIKColliers SecuritiesInitiates Coverage On14.0
SANWLake StreetInitiates Coverage On6.0
LILAMorgan StanleyDowngrades15.0
BEJP MorganUpgrades36.0
NEXACredit SuisseUpgrades11.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at